Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Group 3 Pulmonary Hypertension”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Not applicableNot Yet RecruitingNCT07263958
What this trial is testing

Hemodynamic Effects of Inhaled Iloprost in PH-COPD (HOLLYWOOD)

Who this might be right for
Pulmnary HypertensionCOPDPulmonary Hypertension Secondary to Lung Disease and/or Hypoxia
University of Sao Paulo General Hospital 15
Large-scale testing (Phase 3)Looking for participantsNCT05983250
What this trial is testing

LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF

Who this might be right for
Pulmonary Hypertension
Tenax Therapeutics, Inc. 230
Large-scale testing (Phase 3)Active Not RecruitingNCT04273945
What this trial is testing

Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 935
Testing effectiveness (Phase 2)Study completedNCT02951429
What this trial is testing

Efficacy, Safety, and Tolerability Study of Pirfenidone in Combination With Sildenafil in Participants With Advanced Idiopathic Pulmonary Fibrosis (IPF) and Intermediate or High Probability of Group 3 Pulmonary Hypertension

Who this might be right for
Idiopathic Pulmonary Fibrosis
Hoffmann-La Roche 177
Testing effectiveness (Phase 2)Study completedNCT01265888
What this trial is testing

Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl.

Who this might be right for
Pulmonary Arterial HypertensionIdiopathic Pulmonary Fibrosis
Geno LLC 31
Large-scale testing (Phase 3)Looking for participantsNCT07288398
What this trial is testing

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

Who this might be right for
Pulmonary Hypertension Associated With HFpEF
Tenax Therapeutics, Inc. 540
Not applicableNot Yet RecruitingNCT07478094
What this trial is testing

Longitudinal Outcomes of Patients With Group 3 Pulmonary Hypertension Treated With Iloprost

Who this might be right for
Pulmonary Hypertension Due to Lung Diseases
University of Sao Paulo General Hospital 50
Early research (Phase 1)Study completedNCT02267655
What this trial is testing

3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hypertension Associated w/ COPD and IPF

Who this might be right for
Pulmonary HypertensionChronic Obstructive Pulmonary DiseaseIdiopathic Pulmonary Fibrosis
Bellerophon 8
Large-scale testing (Phase 3)Study completedNCT03904693
What this trial is testing

Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)
Actelion 187
Not applicableActive Not RecruitingNCT06714136
What this trial is testing

The Role of miRNA in Group 3 Pulmonary Hypertension

Who this might be right for
Pulmonary Hypertension
IRCCS Azienda Ospedaliero-Universitaria di Bologna 27
Not applicableStudy completedNCT05001711
What this trial is testing

Acute Assessment of the Aria CV System in Patients With WHO Groups 2 and 3 Pulmonary Hypertension

Who this might be right for
Pulmonary Hypertension
Aria CV, Inc 18
Testing effectiveness (Phase 2)Looking for participantsNCT04778046
What this trial is testing

Pulmonary Hypertension SOLAR

Who this might be right for
Interstitial Lung DiseaseCOPDPulmonary Arterial Hypertension
Bastiaan Driehuys 30
Large-scale testing (Phase 3)Ended earlyNCT04084678
What this trial is testing

Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH

Who this might be right for
PAHPulmonary HypertensionHypertension+8 more
United Therapeutics 10
Large-scale testing (Phase 3)Study completedNCT03399604
What this trial is testing

Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil

Who this might be right for
Primary Pulmonary Hypertension
Liquidia Technologies, Inc. 121
Large-scale testing (Phase 3)Study completedNCT03626688
What this trial is testing

A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

Who this might be right for
PAHPulmonary HypertensionPulmonary Arterial Hypertension+8 more
United Therapeutics 687
Large-scale testing (Phase 3)Ended earlyNCT03689244
What this trial is testing

Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment

Who this might be right for
Chronic Thromboembolic Pulmonary Hypertension
Actelion 128
Large-scale testing (Phase 3)Not Yet RecruitingNCT07285655
What this trial is testing

Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

Who this might be right for
Pulmonary Hypertension Due to Lung Disease (Disorder)
Liquidia Technologies, Inc. 344
Large-scale testing (Phase 3)Not Yet RecruitingNCT07481981
What this trial is testing

Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension
Insmed Incorporated 344
Post-approval studies (Phase 4)UnknownNCT05716984
What this trial is testing

RhBNP in Type 3 Pulmonary Hypertension

Who this might be right for
Group 3 Pulmonary Hypertension
Shengjing Hospital 72
Testing effectiveness (Phase 2)Looking for participantsNCT06475781
What this trial is testing

Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD

Who this might be right for
Group 3 Pulmonary Hypertension
Foresee Pharmaceuticals Co., Ltd. 126
Load More Results